| Indicators | Browse All

Exicure, Inc. (XCUR)

Healthcare | Biotechnology | Redwood City, United States | NasdaqCM
1.29 USD -0.12 (-8.511%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 1.29

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 1:41 a.m. EDT

The immediate outlook is severely clouded by a looming Nasdaq delisting threat, as the company's equity value of $2.1 million falls short of the required $2.5 million threshold. This regulatory overhang creates significant uncertainty that outweighs any potential for a short-term bounce. Looking further ahead, the business fundamentals are deteriorating rapidly; the company is burning through cash with negative operating and free cash flows, while profitability metrics like Return on Equity and Return on Assets are deeply negative. Although the stock recently rallied sharply last year, the current trajectory shows six consecutive years of decline, indicating a structural failure in the business model rather than a temporary setback. With no dividend history to provide income and a balance sheet that appears fragile given the cash burn and low current ratio, there is no compelling case to hold or buy this security.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.422458
AutoARIMA0.513319
AutoETS0.513923
MSTL0.538800

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 34%
H-stat 2.99
Ljung-Box p 0.000
Jarque-Bera p 0.764
Excess Kurtosis -0.12
Attribute Value
Sector Healthcare
Market Cap 8,444,333
Forward P/E -1.68
Beta 3.66
Website https://www.exicuretx.com

Info Dump

Attribute Value
52 Week Change -0.74223036
Address1 400 Seaport Court
Address2 Suite 102
All Time High 975.0
All Time Low 1.05
Ask 1.71
Ask Size 2
Audit Risk 10
Average Daily Volume10 Day 49,850
Average Daily Volume3 Month 412,954
Average Volume 412,954
Average Volume10Days 49,850
Beta 3.663
Bid 1.78
Bid Size 1
Board Risk 10
Book Value 0.329
City Redwood City
Compensation Risk 7
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.29
Current Ratio 0.557
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 1.4
Day Low 1.29
Display Name Exicure
Earnings Timestamp End 1,755,259,200
Earnings Timestamp Start 1,754,909,940
Ebitda -7,110,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.946
Enterprise Value 6,727,333
Eps Forward -0.77
Eps Trailing Twelve Months -1.19
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.7271
Fifty Day Average Change -0.43710005
Fifty Day Average Change Percent -0.25308323
Fifty Two Week Change Percent -74.22304
Fifty Two Week High 9.48
Fifty Two Week High Change -8.19
Fifty Two Week High Change Percent -0.863924
Fifty Two Week Low 1.05
Fifty Two Week Low Change 0.24000001
Fifty Two Week Low Change Percent 0.22857144
Fifty Two Week Range 1.05 - 9.48
Financial Currency USD
First Trade Date Milliseconds 1,526,995,800,000
Float Shares 3,096,125
Forward Eps -0.77
Forward P E -1.6753247
Free Cashflow -3,618,750
Full Exchange Name NasdaqCM
Full Time Employees 1
Fullday Change -0.12
Fullday Change Percent -8.51064
Fullday Price 1.29
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 0.0
Gross Profits 1,257,000
Has Pre Post Market Data 1
Held Percent Insiders 0.41472998
Held Percent Institutions 0.02249
Implied Shares Outstanding 6,545,995
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,724,803,200
Last Split Factor 1:5
Long Business Summary Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Long Name Exicure, Inc.
Market us_market
Market Cap 8,444,333
Market State CLOSED
Max Age 86,400
Message Board Id finmb_82271676
Most Recent Quarter 1,782,777,600
Net Income To Common -8,284,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 9,295,312
Open 1.4
Operating Cashflow -6,704,000
Operating Margins 0.0
Overall Risk 10
Payout Ratio 0.0
Phone 847 673 1700
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 1.29
Post Market Time 1,787,959,806
Previous Close 1.41
Price Hint 4
Price To Book 3.9209726
Profit Margins 0.0
Quick Ratio 0.414
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.12
Regular Market Change Percent -8.51064
Regular Market Day High 1.4
Regular Market Day Low 1.29
Regular Market Day Range 1.29 - 1.4
Regular Market Open 1.4
Regular Market Previous Close 1.41
Regular Market Price 1.29
Regular Market Time 1,787,947,200
Regular Market Volume 18,866
Return On Assets -0.30318
Return On Equity -1.6837399
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 6,545,995
Shares Percent Shares Out 0.0092
Shares Short 60,402
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 506,729
Short Name Exicure, Inc.
Short Percent Of Float 0.0188
Short Ratio 0.06
Source Interval 15
State CA
Symbol XCUR
Total Cash 1,717,000
Total Cash Per Share 0.262
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.19
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.629205
Two Hundred Day Average Change -2.339205
Two Hundred Day Average Change Percent -0.64455026
Type Disp Equity
Volume 18,866
Website https://www.exicuretx.com
Zip 94,063